
### [NCIT:C7215](http://purl.obolibrary.org/obo/NCIT_C7215)
**Label:** Non-Hodgkin Lymphoma by Clinical Course

**Subclasses:** [NCIT:C27410](http://purl.obolibrary.org/obo/NCIT_C27410) (Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma), [NCIT:C27411](http://purl.obolibrary.org/obo/NCIT_C27411) (Colon Mantle Cell Lymphoma), [NCIT:C8159](http://purl.obolibrary.org/obo/NCIT_C8159) (Recurrent Adult Burkitt Lymphoma), [NCIT:C7189](http://purl.obolibrary.org/obo/NCIT_C7189) (Burkitt Lymphoma with Plasmacytoid Differentiation), [NCIT:C8158](http://purl.obolibrary.org/obo/NCIT_C8158) (Recurrent Grade 3 Follicular Lymphoma), [NCIT:C9244](http://purl.obolibrary.org/obo/NCIT_C9244) (Aggressive Non-Hodgkin Lymphoma), [NCIT:C8155](http://purl.obolibrary.org/obo/NCIT_C8155) (Recurrent Grade 1 Follicular Lymphoma), [NCIT:C8156](http://purl.obolibrary.org/obo/NCIT_C8156) (Recurrent Grade 2 Follicular Lymphoma), [NCIT:C7188](http://purl.obolibrary.org/obo/NCIT_C7188) (Classical Burkitt Lymphoma), [NCIT:C7192](http://purl.obolibrary.org/obo/NCIT_C7192) (Grade 3b Follicular Lymphoma), [NCIT:C9252](http://purl.obolibrary.org/obo/NCIT_C9252) (Stage I Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C7194](http://purl.obolibrary.org/obo/NCIT_C7194) (Grade 2 Diffuse Follicular Lymphoma), [NCIT:C7191](http://purl.obolibrary.org/obo/NCIT_C7191) (Grade 3a Follicular Lymphoma), [NCIT:C129599](http://purl.obolibrary.org/obo/NCIT_C129599) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C8849](http://purl.obolibrary.org/obo/NCIT_C8849) (Stage II Burkitt Lymphoma), [NCIT:C8847](http://purl.obolibrary.org/obo/NCIT_C8847) (Refractory Burkitt Lymphoma), [NCIT:C8968](http://purl.obolibrary.org/obo/NCIT_C8968) (Grade 2 Follicular Lymphoma), [NCIT:C8848](http://purl.obolibrary.org/obo/NCIT_C8848) (Stage I Burkitt Lymphoma), [NCIT:C27763](http://purl.obolibrary.org/obo/NCIT_C27763) (Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C8604](http://purl.obolibrary.org/obo/NCIT_C8604) (Recurrent Lymphoplasmacytic Lymphoma), [NCIT:C27409](http://purl.obolibrary.org/obo/NCIT_C27409) (Small Intestinal Burkitt Lymphoma), [NCIT:C8164](http://purl.obolibrary.org/obo/NCIT_C8164) (Recurrent Adult Lymphoblastic Lymphoma), [NCIT:C37203](http://purl.obolibrary.org/obo/NCIT_C37203) (Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation), [NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma), [NCIT:C8937](http://purl.obolibrary.org/obo/NCIT_C8937) (Stage II B Lymphoblastic Lymphoma), [NCIT:C4337](http://purl.obolibrary.org/obo/NCIT_C4337) (Mantle Cell Lymphoma), [NCIT:C3246](http://purl.obolibrary.org/obo/NCIT_C3246) (Mycosis Fungoides), [NCIT:C3366](http://purl.obolibrary.org/obo/NCIT_C3366) (Sezary Syndrome), [NCIT:C8139](http://purl.obolibrary.org/obo/NCIT_C8139) (Stage III Adult Burkitt Lymphoma), [NCIT:C8138](http://purl.obolibrary.org/obo/NCIT_C8138) (Stage III Adult Lymphoblastic Lymphoma), [NCIT:C9464](http://purl.obolibrary.org/obo/NCIT_C9464) (Grade 1 Diffuse Follicular Lymphoma), [NCIT:C8132](http://purl.obolibrary.org/obo/NCIT_C8132) (Stage III Grade 3 Follicular Lymphoma), [NCIT:C123394](http://purl.obolibrary.org/obo/NCIT_C123394) (Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C69144](http://purl.obolibrary.org/obo/NCIT_C69144) (Recurrent Grade III Lymphomatoid Granulomatosis), [NCIT:C45194](http://purl.obolibrary.org/obo/NCIT_C45194) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C80299](http://purl.obolibrary.org/obo/NCIT_C80299) (Pediatric Nodal Marginal Zone Lymphoma), [NCIT:C4340](http://purl.obolibrary.org/obo/NCIT_C4340) (Peripheral T-Cell Lymphoma, Not Otherwise Specified), [NCIT:C4341](http://purl.obolibrary.org/obo/NCIT_C4341) (Marginal Zone Lymphoma), [NCIT:C8145](http://purl.obolibrary.org/obo/NCIT_C8145) (Stage IV Grade 3 Follicular Lymphoma), [NCIT:C8142](http://purl.obolibrary.org/obo/NCIT_C8142) (Stage IV Grade 1 Follicular Lymphoma), [NCIT:C8143](http://purl.obolibrary.org/obo/NCIT_C8143) (Stage IV Grade 2 Follicular Lymphoma), [NCIT:C9361](http://purl.obolibrary.org/obo/NCIT_C9361) (Adult Lymphoblastic Lymphoma), [NCIT:C8151](http://purl.obolibrary.org/obo/NCIT_C8151) (Stage IV Adult Lymphoblastic Lymphoma), [NCIT:C8152](http://purl.obolibrary.org/obo/NCIT_C8152) (Stage IV Adult Burkitt Lymphoma), [NCIT:C39644](http://purl.obolibrary.org/obo/NCIT_C39644) (Mycosis Fungoides Variant), [NCIT:C5768](http://purl.obolibrary.org/obo/NCIT_C5768) (Liver Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C6859](http://purl.obolibrary.org/obo/NCIT_C6859) (Grade 3 Cutaneous Follicular Lymphoma), [NCIT:C3465](http://purl.obolibrary.org/obo/NCIT_C3465) (Grade 1 Follicular Lymphoma), [NCIT:C8119](http://purl.obolibrary.org/obo/NCIT_C8119) (Stage II Grade 3 Follicular Lymphoma), [NCIT:C45163](http://purl.obolibrary.org/obo/NCIT_C45163) (Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C45166](http://purl.obolibrary.org/obo/NCIT_C45166) (Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C8117](http://purl.obolibrary.org/obo/NCIT_C8117) (Stage II Grade 2 Follicular Lymphoma), [NCIT:C5088](http://purl.obolibrary.org/obo/NCIT_C5088) (Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8116](http://purl.obolibrary.org/obo/NCIT_C8116) (Stage II Grade 1 Follicular Lymphoma), [NCIT:C5089](http://purl.obolibrary.org/obo/NCIT_C5089) (Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C9202](http://purl.obolibrary.org/obo/NCIT_C9202) (Stage II Mantle Cell Lymphoma), [NCIT:C68838](http://purl.obolibrary.org/obo/NCIT_C68838) (Unfavorable Non-Hodgkin Lymphoma), [NCIT:C5084](http://purl.obolibrary.org/obo/NCIT_C5084) (Stage IV Burkitt Lymphoma), [NCIT:C5085](http://purl.obolibrary.org/obo/NCIT_C5085) (Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5086](http://purl.obolibrary.org/obo/NCIT_C5086) (Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C7264](http://purl.obolibrary.org/obo/NCIT_C7264) (Diffuse Follicular Lymphoma), [NCIT:C5087](http://purl.obolibrary.org/obo/NCIT_C5087) (Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C68837](http://purl.obolibrary.org/obo/NCIT_C68837) (Favorable Non-Hodgkin Lymphoma), [NCIT:C3460](http://purl.obolibrary.org/obo/NCIT_C3460) (Grade 3 Follicular Lymphoma), [NCIT:C8482](http://purl.obolibrary.org/obo/NCIT_C8482) (Stage III Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C5090](http://purl.obolibrary.org/obo/NCIT_C5090) (Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C115204](http://purl.obolibrary.org/obo/NCIT_C115204) (Childhood Grade III Lymphomatoid Granulomatosis), [NCIT:C9339](http://purl.obolibrary.org/obo/NCIT_C9339) (Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified), [NCIT:C8129](http://purl.obolibrary.org/obo/NCIT_C8129) (Stage III Grade 1 Follicular Lymphoma), [NCIT:C8126](http://purl.obolibrary.org/obo/NCIT_C8126) (Stage II Adult Burkitt Lymphoma), [NCIT:C6860](http://purl.obolibrary.org/obo/NCIT_C6860) (Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C8489](http://purl.obolibrary.org/obo/NCIT_C8489) (Recurrent Mantle Cell Lymphoma), [NCIT:C8487](http://purl.obolibrary.org/obo/NCIT_C8487) (Stage IV Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C4684](http://purl.obolibrary.org/obo/NCIT_C4684) (Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C8488](http://purl.obolibrary.org/obo/NCIT_C8488) (Recurrent Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C8125](http://purl.obolibrary.org/obo/NCIT_C8125) (Stage II Adult Lymphoblastic Lymphoma), [NCIT:C8485](http://purl.obolibrary.org/obo/NCIT_C8485) (Stage IV Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C5095](http://purl.obolibrary.org/obo/NCIT_C5095) (Recurrent Splenic Marginal Zone Lymphoma), [NCIT:C5096](http://purl.obolibrary.org/obo/NCIT_C5096) (Refractory Splenic Marginal Zone Lymphoma), [NCIT:C8486](http://purl.obolibrary.org/obo/NCIT_C8486) (Stage IV Mantle Cell Lymphoma), [NCIT:C8483](http://purl.obolibrary.org/obo/NCIT_C8483) (Stage III Mantle Cell Lymphoma), [NCIT:C8484](http://purl.obolibrary.org/obo/NCIT_C8484) (Stage III Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C8492](http://purl.obolibrary.org/obo/NCIT_C8492) (Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C8130](http://purl.obolibrary.org/obo/NCIT_C8130) (Stage III Grade 2 Follicular Lymphoma), [NCIT:C8490](http://purl.obolibrary.org/obo/NCIT_C8490) (Recurrent Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma), [NCIT:C8491](http://purl.obolibrary.org/obo/NCIT_C8491) (Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C7802](http://purl.obolibrary.org/obo/NCIT_C7802) (Stage IV Mycosis Fungoides), [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8459](http://purl.obolibrary.org/obo/NCIT_C8459) (Hepatosplenic T-Cell Lymphoma), [NCIT:C7800](http://purl.obolibrary.org/obo/NCIT_C7800) (Stage III Mycosis Fungoides), [NCIT:C7245](http://purl.obolibrary.org/obo/NCIT_C7245) (Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C115212](http://purl.obolibrary.org/obo/NCIT_C115212) (Familial Waldenstrom Macroglobulinemia), [NCIT:C45266](http://purl.obolibrary.org/obo/NCIT_C45266) (Cutaneous Mantle Cell Lymphoma), [NCIT:C7244](http://purl.obolibrary.org/obo/NCIT_C7244) (Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C45268](http://purl.obolibrary.org/obo/NCIT_C45268) (Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C7246](http://purl.obolibrary.org/obo/NCIT_C7246) (Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C2912](http://purl.obolibrary.org/obo/NCIT_C2912) (Burkitt Lymphoma), [NCIT:C5635](http://purl.obolibrary.org/obo/NCIT_C5635) (Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C3212](http://purl.obolibrary.org/obo/NCIT_C3212) (Lymphoplasmacytic Lymphoma), [NCIT:C115349](http://purl.obolibrary.org/obo/NCIT_C115349) (Recurrent Adult Grade III Lymphomatoid Granulomatosis), [NCIT:C45271](http://purl.obolibrary.org/obo/NCIT_C45271) (Cutaneous Angioimmunoblastic T-Cell Lymphoma), [NCIT:C4663](http://purl.obolibrary.org/obo/NCIT_C4663) (Splenic Marginal Zone Lymphoma), [NCIT:C7933](http://purl.obolibrary.org/obo/NCIT_C7933) (Grade III Lymphomatoid Granulomatosis), [NCIT:C80375](http://purl.obolibrary.org/obo/NCIT_C80375) (Follicular T-Cell Lymphoma), [NCIT:C8465](http://purl.obolibrary.org/obo/NCIT_C8465) (Stage I Mantle Cell Lymphoma), [NCIT:C8464](http://purl.obolibrary.org/obo/NCIT_C8464) (Stage I Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C4997](http://purl.obolibrary.org/obo/NCIT_C4997) (Refractory Nodal Marginal Zone Lymphoma), [NCIT:C4998](http://purl.obolibrary.org/obo/NCIT_C4998) (Recurrent Nodal Marginal Zone Lymphoma), [NCIT:C7227](http://purl.obolibrary.org/obo/NCIT_C7227) (Refractory T Lymphoblastic Lymphoma), [NCIT:C7226](http://purl.obolibrary.org/obo/NCIT_C7226) (Adult T Lymphoblastic Lymphoma), [NCIT:C8678](http://purl.obolibrary.org/obo/NCIT_C8678) (Stage III Angioimmunoblastic T-cell Lymphoma), [NCIT:C7229](http://purl.obolibrary.org/obo/NCIT_C7229) (Blastoid Variant Mantle Cell Lymphoma), [NCIT:C8679](http://purl.obolibrary.org/obo/NCIT_C8679) (Stage IV Angioimmunoblastic T-cell Lymphoma), [NCIT:C8676](http://purl.obolibrary.org/obo/NCIT_C8676) (Recurrent Angioimmunoblastic T-cell Lymphoma), [NCIT:C8677](http://purl.obolibrary.org/obo/NCIT_C8677) (Stage II Angioimmunoblastic T-cell Lymphoma), [NCIT:C8674](http://purl.obolibrary.org/obo/NCIT_C8674) (Stage III Nasal Type NK/T-Cell Lymphoma), [NCIT:C8675](http://purl.obolibrary.org/obo/NCIT_C8675) (Stage IV Nasal Type NK/T-Cell Lymphoma), [NCIT:C8672](http://purl.obolibrary.org/obo/NCIT_C8672) (Stage I Angioimmunoblastic T-cell Lymphoma), [NCIT:C8673](http://purl.obolibrary.org/obo/NCIT_C8673) (Stage II Nasal Type NK/T-Cell Lymphoma), [NCIT:C8670](http://purl.obolibrary.org/obo/NCIT_C8670) (Stage I Nasal Type NK/T-Cell Lymphoma), [NCIT:C8671](http://purl.obolibrary.org/obo/NCIT_C8671) (Refractory Angioimmunoblastic T-cell Lymphoma), [NCIT:C7220](http://purl.obolibrary.org/obo/NCIT_C7220) (Grade 1 Cutaneous Follicular Lymphoma), [NCIT:C8680](http://purl.obolibrary.org/obo/NCIT_C8680) (Recurrent Enteropathy-Associated T-Cell Lymphoma), [NCIT:C95626](http://purl.obolibrary.org/obo/NCIT_C95626) (Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C9095](http://purl.obolibrary.org/obo/NCIT_C9095) (Childhood Burkitt Lymphoma), [NCIT:C35794](http://purl.obolibrary.org/obo/NCIT_C35794) (Pagetoid Reticulosis), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C115367](http://purl.obolibrary.org/obo/NCIT_C115367) (Recurrent Childhood Grade III Lymphomatoid Granulomatosis), [NCIT:C8687](http://purl.obolibrary.org/obo/NCIT_C8687) (Refractory Mycosis Fungoides), [NCIT:C8685](http://purl.obolibrary.org/obo/NCIT_C8685) (Stage IV Enteropathy-Associated T-Cell Lymphoma), [NCIT:C44960](http://purl.obolibrary.org/obo/NCIT_C44960) (Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C8686](http://purl.obolibrary.org/obo/NCIT_C8686) (Recurrent Mycosis Fungoides), [NCIT:C95991](http://purl.obolibrary.org/obo/NCIT_C95991) (Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8683](http://purl.obolibrary.org/obo/NCIT_C8683) (Stage II Enteropathy-Associated T-Cell Lymphoma), [NCIT:C7230](http://purl.obolibrary.org/obo/NCIT_C7230) (Primary Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8684](http://purl.obolibrary.org/obo/NCIT_C8684) (Stage III Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8681](http://purl.obolibrary.org/obo/NCIT_C8681) (Refractory Enteropathy-Associated T-Cell Lymphoma), [NCIT:C36081](http://purl.obolibrary.org/obo/NCIT_C36081) (Diffuse Large B-Cell Lymphoma Activated B-Cell Type), [NCIT:C8682](http://purl.obolibrary.org/obo/NCIT_C8682) (Stage I Enteropathy-Associated T-Cell Lymphoma), [NCIT:C7209](http://purl.obolibrary.org/obo/NCIT_C7209) (Childhood B Lymphoblastic Lymphoma), [NCIT:C5026](http://purl.obolibrary.org/obo/NCIT_C5026) (Recurrent Nasal Type NK/T-Cell Lymphoma), [NCIT:C45340](http://purl.obolibrary.org/obo/NCIT_C45340) (Primary Cutaneous Gamma-Delta T-Cell Lymphoma), [NCIT:C7205](http://purl.obolibrary.org/obo/NCIT_C7205) (Lymphoepithelioid Variant Peripheral T-Cell Lymphoma), [NCIT:C7204](http://purl.obolibrary.org/obo/NCIT_C7204) (T-Zone Variant Peripheral T-Cell Lymphoma), [NCIT:C8656](http://purl.obolibrary.org/obo/NCIT_C8656) (Stage IV Lymphoplasmacytic Lymphoma), [NCIT:C8654](http://purl.obolibrary.org/obo/NCIT_C8654) (Stage II Lymphoplasmacytic Lymphoma), [NCIT:C5264](http://purl.obolibrary.org/obo/NCIT_C5264) (Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C8655](http://purl.obolibrary.org/obo/NCIT_C8655) (Stage III Lymphoplasmacytic Lymphoma), [NCIT:C5266](http://purl.obolibrary.org/obo/NCIT_C5266) (Gastric Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C8652](http://purl.obolibrary.org/obo/NCIT_C8652) (Refractory Lymphoplasmacytic Lymphoma), [NCIT:C8653](http://purl.obolibrary.org/obo/NCIT_C8653) (Stage I Lymphoplasmacytic Lymphoma), [NCIT:C9189](http://purl.obolibrary.org/obo/NCIT_C9189) (Recurrent Childhood Burkitt Lymphoma), [NCIT:C9187](http://purl.obolibrary.org/obo/NCIT_C9187) (Stage III Childhood Burkitt Lymphoma), [NCIT:C9188](http://purl.obolibrary.org/obo/NCIT_C9188) (Stage IV Childhood Burkitt Lymphoma), [NCIT:C37196](http://purl.obolibrary.org/obo/NCIT_C37196) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C6919](http://purl.obolibrary.org/obo/NCIT_C6919) (T Lymphoblastic Lymphoma), [NCIT:C68692](http://purl.obolibrary.org/obo/NCIT_C68692) (Childhood Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C4737](http://purl.obolibrary.org/obo/NCIT_C4737) (Enteropathy-Associated T-Cell Lymphoma), [NCIT:C6918](http://purl.obolibrary.org/obo/NCIT_C6918) (Subcutaneous Panniculitis-Like T-Cell Lymphoma), [NCIT:C6917](http://purl.obolibrary.org/obo/NCIT_C6917) (Atypical Burkitt/Burkitt-Like Lymphoma), [NCIT:C3898](http://purl.obolibrary.org/obo/NCIT_C3898) (Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C7219](http://purl.obolibrary.org/obo/NCIT_C7219) (Grade 2 Cutaneous Follicular Lymphoma), [NCIT:C8669](http://purl.obolibrary.org/obo/NCIT_C8669) (Refractory Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C7216](http://purl.obolibrary.org/obo/NCIT_C7216) (Non-Hodgkin Lymphoma with Variable Clinical Course), [NCIT:C7338](http://purl.obolibrary.org/obo/NCIT_C7338) (Adult B Lymphoblastic Lymphoma), [NCIT:C45231](http://purl.obolibrary.org/obo/NCIT_C45231) (Diffuse Large B-Cell Lymphoma Unclassifiable), [NCIT:C7217](http://purl.obolibrary.org/obo/NCIT_C7217) (Primary Cutaneous Follicle Center Lymphoma), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C37194](http://purl.obolibrary.org/obo/NCIT_C37194) (Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C7210](http://purl.obolibrary.org/obo/NCIT_C7210) (Childhood T Lymphoblastic Lymphoma), [NCIT:C35688](http://purl.obolibrary.org/obo/NCIT_C35688) (Breast Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C96502](http://purl.obolibrary.org/obo/NCIT_C96502) (Colorectal Burkitt Lymphoma), [NCIT:C96505](http://purl.obolibrary.org/obo/NCIT_C96505) (Colorectal Mantle Cell Lymphoma), [NCIT:C96506](http://purl.obolibrary.org/obo/NCIT_C96506) (Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C35689](http://purl.obolibrary.org/obo/NCIT_C35689) (Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C5008](http://purl.obolibrary.org/obo/NCIT_C5008) (Recurrent Burkitt Lymphoma), [NCIT:C7309](http://purl.obolibrary.org/obo/NCIT_C7309) (Splenic Burkitt Lymphoma), [NCIT:C8878](http://purl.obolibrary.org/obo/NCIT_C8878) (Stage III Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8879](http://purl.obolibrary.org/obo/NCIT_C8879) (Stage IV Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8876](http://purl.obolibrary.org/obo/NCIT_C8876) (Stage I Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C27694](http://purl.obolibrary.org/obo/NCIT_C27694) (EBV-Related Burkitt Lymphoma), [NCIT:C7306](http://purl.obolibrary.org/obo/NCIT_C7306) (Splenic Mantle Cell Lymphoma), [NCIT:C8877](http://purl.obolibrary.org/obo/NCIT_C8877) (Stage II Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C7305](http://purl.obolibrary.org/obo/NCIT_C7305) (Splenic Lymphoplasmacytic Lymphoma), [NCIT:C8874](http://purl.obolibrary.org/obo/NCIT_C8874) (Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8875](http://purl.obolibrary.org/obo/NCIT_C8875) (Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8872](http://purl.obolibrary.org/obo/NCIT_C8872) (Stage III B Lymphoblastic Lymphoma), [NCIT:C8873](http://purl.obolibrary.org/obo/NCIT_C8873) (Stage IV B Lymphoblastic Lymphoma), [NCIT:C115154](http://purl.obolibrary.org/obo/NCIT_C115154) (Adult Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C8870](http://purl.obolibrary.org/obo/NCIT_C8870) (Refractory B Lymphoblastic Lymphoma), [NCIT:C8871](http://purl.obolibrary.org/obo/NCIT_C8871) (Stage I B Lymphoblastic Lymphoma), [NCIT:C8079](http://purl.obolibrary.org/obo/NCIT_C8079) (Stage I Adult Lymphoblastic Lymphoma), [NCIT:C115150](http://purl.obolibrary.org/obo/NCIT_C115150) (Adult Grade III Lymphomatoid Granulomatosis), [NCIT:C68678](http://purl.obolibrary.org/obo/NCIT_C68678) (Stage I Marginal Zone Lymphoma), [NCIT:C68679](http://purl.obolibrary.org/obo/NCIT_C68679) (Stage II Marginal Zone Lymphoma), [NCIT:C8080](http://purl.obolibrary.org/obo/NCIT_C8080) (Stage I Adult Burkitt Lymphoma), [NCIT:C138027](http://purl.obolibrary.org/obo/NCIT_C138027) (Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C7798](http://purl.obolibrary.org/obo/NCIT_C7798) (Stage II Mycosis Fungoides), [NCIT:C138028](http://purl.obolibrary.org/obo/NCIT_C138028) (Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C27441](http://purl.obolibrary.org/obo/NCIT_C27441) (Small Intestinal Mantle Cell Lymphoma), [NCIT:C27440](http://purl.obolibrary.org/obo/NCIT_C27440) (Gastric Mantle Cell Lymphoma), [NCIT:C7311](http://purl.obolibrary.org/obo/NCIT_C7311) (Splenic T Lymphoblastic Lymphoma), [NCIT:C7310](http://purl.obolibrary.org/obo/NCIT_C7310) (Splenic B Lymphoblastic Lymphoma), [NCIT:C7796](http://purl.obolibrary.org/obo/NCIT_C7796) (Stage I Mycosis Fungoides), [NCIT:C5498](http://purl.obolibrary.org/obo/NCIT_C5498) (Colon Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C5251](http://purl.obolibrary.org/obo/NCIT_C5251) (Gastric Burkitt Lymphoma), [NCIT:C45339](http://purl.obolibrary.org/obo/NCIT_C45339) (Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma), [NCIT:C9185](http://purl.obolibrary.org/obo/NCIT_C9185) (Stage I Childhood Burkitt Lymphoma), [NCIT:C9186](http://purl.obolibrary.org/obo/NCIT_C9186) (Stage II Childhood Burkitt Lymphoma), [NCIT:C9062](http://purl.obolibrary.org/obo/NCIT_C9062) (Adult Burkitt Lymphoma), [NCIT:C68688](http://purl.obolibrary.org/obo/NCIT_C68688) (Stage II Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C68686](http://purl.obolibrary.org/obo/NCIT_C68686) (Stage II Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C68683](http://purl.obolibrary.org/obo/NCIT_C68683) (Stage IV Marginal Zone Lymphoma), [NCIT:C68684](http://purl.obolibrary.org/obo/NCIT_C68684) (Recurrent Marginal Zone Lymphoma), [NCIT:C68682](http://purl.obolibrary.org/obo/NCIT_C68682) (Stage III Marginal Zone Lymphoma), [NCIT:C7528](http://purl.obolibrary.org/obo/NCIT_C7528) (Angioimmunoblastic T-Cell Lymphoma), [NCIT:C27914](http://purl.obolibrary.org/obo/NCIT_C27914) (Sporadic Burkitt Lymphoma), [NCIT:C27915](http://purl.obolibrary.org/obo/NCIT_C27915) (Immunodeficiency-Related Burkitt Lymphoma), [NCIT:C8850](http://purl.obolibrary.org/obo/NCIT_C8850) (Stage III Burkitt Lymphoma), [NCIT:C53282](http://purl.obolibrary.org/obo/NCIT_C53282) (Early Unfavorable Non-Hodgkin Lymphoma), [NCIT:C53280](http://purl.obolibrary.org/obo/NCIT_C53280) (Early Favorable Non-Hodgkin Lymphoma), [NCIT:C80307](http://purl.obolibrary.org/obo/NCIT_C80307) (Waldenstrom Macroglobulinemia), [NCIT:C27465](http://purl.obolibrary.org/obo/NCIT_C27465) (Colon Burkitt Lymphoma), [NCIT:C8869](http://purl.obolibrary.org/obo/NCIT_C8869) (Recurrent B Lymphoblastic Lymphoma), [NCIT:C8867](http://purl.obolibrary.org/obo/NCIT_C8867) (Stage IV Nodal Marginal Zone Lymphoma), [NCIT:C8504](http://purl.obolibrary.org/obo/NCIT_C8504) (Indolent Non-Hodgkin Lymphoma), [NCIT:C8868](http://purl.obolibrary.org/obo/NCIT_C8868) (B Lymphoblastic Lymphoma), [NCIT:C8865](http://purl.obolibrary.org/obo/NCIT_C8865) (Stage II Nodal Marginal Zone Lymphoma), [NCIT:C8866](http://purl.obolibrary.org/obo/NCIT_C8866) (Stage III Nodal Marginal Zone Lymphoma), [NCIT:C8863](http://purl.obolibrary.org/obo/NCIT_C8863) (Nodal Marginal Zone Lymphoma), [NCIT:C8864](http://purl.obolibrary.org/obo/NCIT_C8864) (Stage I Nodal Marginal Zone Lymphoma), [NCIT:C8862](http://purl.obolibrary.org/obo/NCIT_C8862) (Refractory Mantle Cell Lymphoma), [NCIT:C8072](http://purl.obolibrary.org/obo/NCIT_C8072) (Stage I Grade 2 Follicular Lymphoma), [NCIT:C8073](http://purl.obolibrary.org/obo/NCIT_C8073) (Stage I Grade 3 Follicular Lymphoma), [NCIT:C9280](http://purl.obolibrary.org/obo/NCIT_C9280) (Mediastinal (Thymic) Large B-Cell Lymphoma), [NCIT:C8071](http://purl.obolibrary.org/obo/NCIT_C8071) (Stage I Grade 1 Follicular Lymphoma), [NCIT:C127840](http://purl.obolibrary.org/obo/NCIT_C127840) (Recurrent Waldenstrom Macroglobulinemia), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40206](http://purl.obolibrary.org/obo/NCIT_C40206) (Cervical Mucinous Adenocarcinoma, Minimal Deviation Type))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40205](http://purl.obolibrary.org/obo/NCIT_C40205) (Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40203](http://purl.obolibrary.org/obo/NCIT_C40203) (Cervical Mucinous Adenocarcinoma, Intestinal-Type))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40201](http://purl.obolibrary.org/obo/NCIT_C40201) (Cervical Serous Adenocarcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40194](http://purl.obolibrary.org/obo/NCIT_C40194) (Cervical Squamotransitional Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40191](http://purl.obolibrary.org/obo/NCIT_C40191) (Cervical Warty Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 40.36%


